Caliway Biopharmaceuticals Co (TPE:6919) EPS (Basic) : NT$-2.67 (TTM As of Mar. 2025)

View and export this data going back to 2022. Start your Free Trial

What is Caliway Biopharmaceuticals Co EPS (Basic)?

Caliway Biopharmaceuticals Co's basic earnings per share (Basic EPS) for the three months ended in Mar. 2025 was NT$-0.11. Its basic earnings per share (Basic EPS) for the trailing twelve months (TTM) ended in Mar. 2025 was NT$-2.67.

Caliway Biopharmaceuticals Co's EPS (Diluted) for the three months ended in Mar. 2025 was NT$-0.11. Its EPS (Diluted) for the trailing twelve months (TTM) ended in Mar. 2025 was NT$-2.74.

Caliway Biopharmaceuticals Co's EPS without NRI for the three months ended in Mar. 2025 was NT$-0.11. Its EPS without NRIearnings per share without non-recurring items for the trailing twelve months (TTM) ended in Mar. 2025 was -2.74.

During the past 3 years, the average EPS without NRI Growth Rate was 5.40% per year. During the past 5 years, the average EPS without NRI Growth Rate was -7.20% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EPS without NRI Growth Rate using EPS without NRI data.

During the past 6 years, Caliway Biopharmaceuticals Co's highest 3-Year average EPS without NRI Growth Rate was 11.20% per year. The lowest was -28.80% per year. And the median was 5.40% per year.

Caliway Biopharmaceuticals Co EPS (Basic) Historical Data

The historical data trend for Caliway Biopharmaceuticals Co's EPS (Basic) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Caliway Biopharmaceuticals Co EPS (Basic) Chart

Caliway Biopharmaceuticals Co Annual Data

Trend

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

EPS (Basic)

Get a 7-Day Free Trial

-1.85

-4.87

-2.44

-3.94

-4.12

Caliway Biopharmaceuticals Co Quarterly Data
	Dec19	Dec20	Dec21	Jun22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25
EPS (Basic)	Get a 7-Day Free Trial									-0.16	-1.27	-0.99	-0.30	-0.11

Caliway Biopharmaceuticals Co EPS (Basic) Calculation

EPS (Basic) is a rough measurement of the amount of a company's profit that can be allocated to one share of its stock. Basic earnings per share (EPS) do not factor in the dilutive effects on convertible securities.

Caliway Biopharmaceuticals Co's Basic EPS for the fiscal year that ended in Dec. 2024 is calculated as

Basic EPS (A: Dec. 2024 )	=	(Net Income	-	Preferred Dividends)	/	Shares Outstanding (Basic Average)
	=	(-588.83	-	0)	/	142.969
	=	-4.12

Caliway Biopharmaceuticals Co's Basic EPS for the quarter that ended in Mar. 2025 is calculated as

Basic EPS (Q: Mar. 2025 )	=	(Net Income	-	Preferred Dividends)	/	Shares Outstanding (Basic Average)
	=	(-175.565	-	0)	/	1535.961
	=	-0.11

EPS (Basic) for the trailing twelve months (TTM) ended in Mar. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was NT$-2.67

Caliway Biopharmaceuticals Co (TPE:6919) EPS (Basic) Explanation

EPS is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists EPS without NRI, which better reflects the company's underlying performance.

Be Aware

Compared with Earnings per share, a company's cash flow is better indicator of the company's earnings power.

If a company's earnings per share is less than cash flow per share over long term, investors need to be cautious and find out why.

Caliway Biopharmaceuticals Co EPS (Basic) Related Terms

Thank you for viewing the detailed overview of Caliway Biopharmaceuticals Co's EPS (Basic) provided by GuruFocus.com. Please click on the following links to see related term pages.

Caliway Biopharmaceuticals Co Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Caliway Biopharmaceuticals Co Ltd (TPE:6919) » Definitions » EPS (Basic)

Comparable Companies

Traded in Other Exchanges

N/A

Address

No.99, Sec. 1, Xintai 5th Road, 32rd Floor-9, Xizhi District, New Taipei City, TWN, 221

Website

https://www.caliway.com.tw

Caliway Biopharmaceuticals Co Ltd specializes in the development of new drugs for aesthetic medicine and chronic inflammation. Its pipeline candidates are CBL-514, CBA-539, and CBO-012.

Caliway Biopharmaceuticals Co Headlines

No Headlines